Allergan
In Leon Cooperman's portfolio · Omega Advisors
Ticker AGN
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Omega Advisors 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q3 2017 | Sell | 0 | |
| Q2 2017 | No change | 295,188 | 3.0% |
| Q1 2017 | Reduce 19% | 295,188 | 2.8% |
| Q4 2016 | Reduce 33% | 363,788 | 3.4% |
| Q3 2016 | Reduce 19% | 541,122 | 3.8% |
| Q2 2016 | Add 20% | 671,212 | 4.4% |
| Q1 2016 | Reduce 28% | 561,265 | 4.0% |
| Q4 2015 | Reduce 4% | 781,780 | 5.3% |
| Q3 2015 | Reduce 12% | 811,635 | 4.5% |
| Q2 2015 | Reduce 1% | 922,375 | 4.5% |
| Q1 2015 | Reduce 1% | 933,475 | 4.4% |
| Q4 2014 | Add 34% | 943,572 | 4.1% |
| Q3 2014 | Add 14% | 706,472 | 2.5% |
| Q2 2014 | Add 135% | 619,919 | 1.8% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.